Poly(ADP-ribose) polymerase-1 inhibition reverses temozolomide resistance in a DNA mismatch repair–deficient malignant glioma xenograft
Data up to Jan 2025
Total Citations Per Year
Abstract
References (31)
Genome maintenance mechanisms for preventing cancer
2001 • 3,819 citations
The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors
2002 • 1,352 citations
A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse
2000 • 940 citations
Multicenter Phase II Trial of Temozolomide in Patients With Anaplastic Astrocytoma or Anaplastic Oligoastrocytoma at First Relapse
1999 • 762 citations
Mammalian O6-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents.
1990 • 736 citations
DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma.
1998 • 413 citations
Involvement of the Mismatch Repair System in Temozolomide-Induced Apoptosis
1998 • 275 citations
Mismatch repair mutations override alkyltransferase in conferring resistance to temozolomide but not to 1,3-bis(2-chloroethyl)nitrosourea.
1996 • 236 citations
Effect of O6-benzylguanine analogues on sensitivity of human tumor cells to the cytotoxic effects of alkylating agents.
1991 • 229 citations
Systemic administration of GPI 15427, a novel poly(ADP-ribose) polymerase-1 inhibitor, increases the antitumor activity of temozolomide against intracranial melanoma, glioma, lymphoma.
2003 • 200 citations
Novel Poly(ADP-ribose) Polymerase-1 Inhibitor, AG14361, Restores Sensitivity to Temozolomide in Mismatch Repair-Deficient Cells
2004 • 163 citations
Pharmacologic disruption of base excision repair sensitizes mismatch repair-deficient and -proficient colon cancer cells to methylating agents.
1999 • 160 citations
Activity of temozolomide in the treatment of central nervous system tumor xenografts.
1995 • 145 citations
Potential clinical applications of poly(ADP-ribose) polymerase (PARP) inhibitors
2002 • 143 citations
The basis for current treatment recommendations for malignant gliomas
1994 • 135 citations
Methylator resistance mediated by mismatch repair deficiency in a glioblastoma multiforme xenograft.
1997 • 132 citations
3-aminobenzamide and/or O6-benzylguanine evaluated as an adjuvant to temozolomide or BCNU treatment in cell lines of variable mismatch repair status and O6-alkylguanine-DNA alkyltransferase activity
1996 • 121 citations
Poly(ADP-Ribose) Polymerase Promotes Cardiac Remodeling, Contractile Failure, and Translocation of Apoptosis-Inducing Factor in a Murine Experimental Model of Aortic Banding and Heart Failure
2004 • 103 citations
Effect of poly(ADP ribose) synthetase inhibition on burn and smoke inhalation injury in sheep
2003 • 101 citations
Activity of 9-dimethylaminomethyl-10-hydroxycamptothecin against pediatric and adult central nervous system tumor xenografts
1994 • 86 citations
Combined treatment with temozolomide and poly(ADP-ribose) polymerase inhibitor enhances survival of mice bearing hematologic malignancy at the central nervous system site
2002 • 82 citations
Peroxynitrite Production, DNA Breakage, and Poly(ADP-ribose) Polymerase Activation in a Mouse Model of Oxazolone-Induced Contact Hypersensitivity
2001 • 70 citations
Poly(ADP‐ribose) polymerase inhibitor increases growth inhibition and reduces G2/M cell accumulation induced by temozolomide in malignant glioma cells
2002 • 65 citations
Radiosensitization of human and rodent cell lines by INO-1001, a novel inhibitor of poly(ADP-ribose) polymerase
2004 • 65 citations
Poly(ADP-Ribose) Polymerase Contributes to the Development of Myocardial Infarction in Diabetic Rats and Regulates the Nuclear Translocation of Apoptosis-Inducing Factor
2004 • 62 citations
Triazene compounds induce apoptosis in O6-alkylguanine-DNA alkyltransferase deficient leukemia cell lines.
1995 • 51 citations
Antitumor imidazotetrazines. 20. Preparation of the 8-acid derivative of mitozolomide and its utility in the preparation of active antitumor agents
1990 • 42 citations
Brain tumor cell lines resistant to O6-benzylguanine/1,3-bis(2-chloroethyl)-1-nitrosourea chemotherapy have O6-alkylguanine-DNA alkyltransferase mutations
2004 • 37 citations
Heterotransplantation of Human Craniopharyngiomas in Athymic “Nude” Mice
1979 • 33 citations
Activation of Poly(ADP-Ribose) Polymerase in Circulating Leukocytes During Myocardial Infarction
2004 • 25 citations
PARP and PARG as novel therapeutic targets
2002 • 10 citations
Cited By (0)
No citing papers found in database